Multiple sclerosis (MS)

(See separate entry for MS-RRMS short-term therapy)

For the following indications, there is insufficient or no evidence to support the use of IG. Alternatives to IG are often available.

RecommendationsRecommendation includes but is not limited to:
  • Relapsing remitting multiple sclerosis (RRMS), Long-term therapy.
  • Primary Progressive Multiple Sclerosis, progressive phase of MS without relapse.
IG is not recommended.